Thurston, Springer, Miller, Herd & Titak, Inc. Boston Scientific Corp Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $475 Million
- Q4 2024
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 5,585 shares of BSX stock, worth $567,659. This represents 0.1% of its overall portfolio holdings.
Number of Shares
5,585
Previous 3,786
47.52%
Holding current value
$567,659
Previous $317,000
57.1%
% of portfolio
0.1%
Previous 0.1%
Shares
3 transactions
Others Institutions Holding BSX
# of Institutions
1,566Shares Held
1.18BCall Options Held
6.78MPut Options Held
10.1M-
Vanguard Group Inc Valley Forge, PA131MShares$13.3 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY126MShares$12.8 Billion0.22% of portfolio
-
State Street Corp Boston, MA62.8MShares$6.39 Billion0.22% of portfolio
-
Primecap Management CO Pasadena, CA37.8MShares$3.84 Billion2.37% of portfolio
-
Wellington Management Group LLP Boston, MA32.8MShares$3.34 Billion0.49% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $146B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...